Company Filing History:
1 out of 504 
1 out of 81 Years Active: 2013
Title: Rainer Kalscheuer: Innovator in Chemotherapeutic Methods
Introduction
Rainer Kalscheuer is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of chemotherapeutic agents, particularly in methods targeting alpha-glucan pathways. His innovative work has the potential to impact the treatment of bacterial infections.
Latest Patents
Kalscheuer holds a patent for "Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof." This invention provides methods for determining a putative antibacterial, which includes assessing whether the putative antibacterial inhibits GlgE or Rv3032. The patent also encompasses the antibacterial itself, a pharmaceutical composition, and methods for treating subjects infected with bacteria through the administration of the antibacterial.
Career Highlights
Throughout his career, Rainer Kalscheuer has worked with esteemed institutions such as the Albert Einstein College of Medicine and Plant Bioscience Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of pharmaceuticals.
Collaborations
Kalscheuer has collaborated with notable individuals in his field, including William R Jacobs, Jr. and Stephen Bornemann. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Rainer Kalscheuer's work in developing methods for determining chemotherapeutic agents showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against bacterial infections, and his innovative spirit continues to inspire future research in this vital area.